Hurriyet.com.tr/INTERNATIONAL NEWS
The expected news in the updated vaccines for Omicron’s sub-variant BA.4 and BA.5, which has become the dominant variant in most countries and can escape from the current vaccines, came today. The US Food and Drug Administration (FDA) is expected to approve new coronavirus vaccines this week. So how did new vaccines get approval so quickly? Here is the answer to the question everyone is wondering…
Two years that turned our lives upside down. coronavirus As we prepare to take a full sigh of relief in the pandemic, OmicronThe sub-variants BA.4 and BA.5 have once again become a cause for concern for all of us.
BA.4 and BA.5, which are highly contagious and have become the dominant variants in most countries, have both innate immunity and vaccine With the discovery that they managed to escape the immunity provided by the vaccine, vaccine manufacturers rolled up their sleeves again.
While both Moderna and Pfizer-BioNTech are adapting their current vaccines according to Omicron, the expected news for the vaccines that everyone has been eagerly waiting for came today.
FDA TO APPROVE VACCINES THIS WEEK
The US Food and Drug Administration (FDA) is expected to approve new coronavirus vaccines this week, according to a new report by the Wall Street Journal.
class=”medianet-inline-adv”>
The new vaccines contain the same ingredients as existing coronavirus vaccines, with only a few minor changes to be effective on the Omicron variant. For this reason, approval processes have progressed faster than previous vaccines.
Moderna has announced that it will be able to supply the vaccines in the next few weeks. However, it is not yet known which countries will receive these vaccines.
LIKE UPDATES TO FLU VACCINES
Without waiting for these vaccines to be tested on humans, the FDA will use data from experiments on mice.
FDA Commissioner Dr. Robert Califf said in a statement on the subject, “Evidence from existing mRNA Covid-19 vaccines administered to millions of people shows us that the vaccines are safe” said.
Emphasizing that updating existing vaccines to protect against different strains does not require a change in vaccine content, Califf stated that this is a common practice in flu vaccines and added;
“The FDA has extensive experience in reviewing strain changes in vaccines, as does the annual flu shot.”
The European Medicines Agency (EMA) announced that the updated vaccines would be approved by autumn.
class=”medianet-inline-adv”>
ENGLAND WAS THE FIRST COUNTRY TO APPROVE
An intense vaccination campaign is expected to begin next fall, with approval of both Moderna and Pfizer-BioNTech’s updated vaccines for the Omciron variant.
The UK has become the first country to approve a vaccine developed by the US-based company Moderna, developed against both the original coronavirus and the Omicron variant of the virus.
After Moderna, Pfizer is expected to begin human trials later this month.
Professor William Schaffner of Vanderbilt University pointed out that clinical trials take a long time and “If we had waited for clinical-trial results, the vaccines would only come in the spring. These vaccines are just an update of the vaccines we have used before.” said.
.